Tardiff Daniel
Chief Scientific Officer
Tardiff Daniel has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Tardiff Daniel is listed as Chief Scientific Officer at Camp4 Therapeutics Corp. Inside the rolling window, Tardiff Daniel reported no open-market purchases and 1 open-market sale totaling $8K in CAMP.
Companies traded
Other insiders at CAMP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tardiff Daniel made?
Tardiff Daniel has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Tardiff Daniel trade?
Tardiff Daniel has filed SEC Form 4 disclosures for 1 company, including CAMP.
When was Tardiff Daniel's most recent SEC Form 4 filing?
Tardiff Daniel's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Tardiff Daniel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tardiff Daniel is listed as Chief Scientific Officer.
What is Tardiff Daniel's total buy and sell value in the current window?
Inside the rolling retention window, Tardiff Daniel bought $0 and sold $8K based on SEC Form 4 filings.
What was Tardiff Daniel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,738 CAMP shares on 2026-08-19, worth $8K, per SEC Form 4 filings.